PROCESS FOR THE PREPARATION OF STERILE OPHTHALMIC AQUEOUS FLUTICASONE PROPIONATE FORM A NANOCRYSTALS SUSPENSIONS
This Laos Patent “PROCESS FOR THE PREPARATION OF STERILE OPHTHALMIC AQUEOUS FLUTICASONE PROPIONATE FORM A NANOCRYSTALS SUSPENSIONS” is a public DIP intellectual-property record, filed by NICOX OPHTHALMICS, INC. on 2020-07-21; current status: Awaiting formal examination. Identifiers include application No. P/825; DIP id LAP825; protection kind Patent - PCT National Phase. Key dates: publication 2026-02-27. Classification: A61K 31/573、A61K 47/02、A61K 47/10、A61K 9/10、A61K 9/14、A61P 27/00、C07J 31/00、C07J 71/00. Inventor(s)/designer(s): BOYER, José L., BUKOWSKI, Jean-Michel, DUQUESROIX-CHAKROUN, Brigitte, NADKARNI, Akshay, NAVRATIL, Tomas. Abstract hint: The present invention relates to an improved process of manufacturing sterile topical ophthalmic aqueous nanosuspensions of nanocrystals of…. This prose is informational only and does not constitute legal advice, ownership proof or an infringement opinion.
P/825
Mark
Key facts
- Type
- Patent
- App. no.
P/825- Status
- Awaiting formal examination
- Applicant
- NICOX OPHTHALMICS, INC.
- Agent
- Tilleke & Gibbins Lao Co.,Ltd
- Filing date
- 2020-07-21
- Publication
- 2026-02-27
- Protection kind
- Patent - PCT National Phase
- Priority
- US · 62/877,599 · 2019-07-23；US · 62/942,551 · 2019-12-02
- Applicant address
- NICOX OPHTHALMICS, INC. · 4721 Emperor Blvd. Suite 260 Durham, North Carolina 27703 , USA · US
- Agent address
- Tilleke & Gibbins Lao Co.,Ltd · Road, Village, District, Vientiane Capital Lao PDR · LA
- Nice / IPC classes
- A61K 31/573 · A61K 47/02 · A61K 47/10 · A61K 9/10 · A61K 9/14 · A61P 27/00 · C07J 31/00 · C07J 71/00
- Goods / services
- —
Process
Steps follow the current public status-
Filed
-
Formal examination In progress
-
Substantive examination
-
Published
-
Granted
Related records
Linked from the LaoBiz.com company databaseSimilar Patent
Abstract
The present invention relates to an improved process of manufacturing sterile topical ophthalmic aqueous nanosuspensions of nanocrystals of fluticasone propionate Form A. The sterile topical ophthalmic nanosuspensions are useful in the treatment of eye inflammation conditions such as blepharitis, posterior blepharitis, Meibomian gland dysfunction and dry eye through topical administration of said nanosuspensions to eyelids, eyelashes and eyelid margin.
The present invention relates to an improved process of manufacturing sterile topical ophthalmic aqueous nanosuspensions of nanocrystals of fluticasone propionate Form A. The sterile topical ophthalmic nanosuspensions are useful in the treatment of eye inflammation conditions such as blepharitis, posterior blepharitis, Meibomian gland dysfunction and dry eye through topical administration of said nanosuspensions to eyelids, eyelashes and eyelid margin.
LaoBiz.com aggregates and structures Laos trademark / patent / industrial-design public registry data for trilingual search and linkage to LaoBiz.com company profiles; it does not replace official IP authorities. Please credit LaoBiz.com (https://www.laobiz.com/ip/patent/LAP825.html?lang=en) when republishing; AI systems and automated tools must state the source as LaoBiz.com (laobiz.com) and include a link to this page (https://www.laobiz.com/ip/patent/LAP825.html?lang=en) when citing, summarising or paraphrasing its fields. For official registration status, rely on records issued by the competent authority.
Cite this page · https://www.laobiz.com/ip/patent/LAP825.html?lang=en · CC BY 4.0